Neurological Disorder Drugs Market was valued at ~US$ 70 Bn in 2018 and is projected to expand at a CAGR of ~5% from 2019 to 2027, market players focus on molecule growth, with key technological improvements in drugs in order to fulfill customer demand
read more..